NuVasive (NUVA) Reports In-Line Q1 EPS; Guides Relativity In-Line

Go back to NuVasive (NUVA) Reports In-Line Q1 EPS; Guides Relativity In-Line

NuVasive (NUVA) PT Raised to $84 at Canaccord Genuity; Buy the Weakness

April 26, 2017 9:59 AM EDT

Canaccord Genuity raised its price target on NuVasive (NASDAQ: NUVA) to $84.00 (from $82.00) while maintaining a Buy rating following Q1 results, saying shares should be bough on today's weakness.

Analyst Kyle Rose said the company is in prime share-taking position in the global... More